Patents by Inventor Susan Beth Sobolov-Jaynes

Susan Beth Sobolov-Jaynes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 11C-labeled benzyl-lactam compounds and their use as imaging agents
    Patent number: 8012969
    Abstract: The invention relates to “C-labeled compounds, their preparation, compositions comprising an effective amount of a “C-labeled compound, and the use of a “C-labeled compound as a radiopharmaceutical for positron emission tomography.
    Type: Grant
    Filed: January 11, 2006
    Date of Patent: September 6, 2011
    Assignee: GE Healthcare Limited
    Inventors: Christopher John Helal, Gunnar Antoni, Bengt Langstrom, Jia Zhi Sheng, Susan Beth Sobolov-Jaynes, Timothy James McCarthy
  • Benzoamide piperidine containing compounds and related compounds
    Patent number: 7119207
    Abstract: The present invention relates to certain benzoamide piperidine containing compounds and related compounds that exhibit activity as NK-1 receptor antagonists, (e.g., substance P receptor antagonists), to pharmaceutical compositions containing them, and to their use in the treatment and prevention of central nervous system disorders, inflammatory disorders, cardiovascular disorders, ophthalmic disorders, gastrointestinal disorders, disorders caused by helicobacter pylori, disorders of the immune system, urinary incontinence, pain, migraine, emesis, angiogenesis and other disorders.
    Type: Grant
    Filed: March 16, 2001
    Date of Patent: October 10, 2006
    Assignee: Pfizer INC
    Inventors: Brian Thomas O'Neill, Arthur Adam Nagel, John Michael Humphrey, Susan Beth Sobolov-Jaynes, Thomas Allen Chappie, Lawrence Albert Vincent, Eric Platt Arnold, Jianhua Huang
  • Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
    Publication number: 20030162795
    Abstract: The invention relates to compounds of the formulas 1 and 2 1
    Type: Application
    Filed: September 16, 2002
    Publication date: August 28, 2003
    Applicant: Pfizer Inc.
    Inventors: Michael John Munchhof, Susan Beth Sobolov-Jaynes, Matthew Arnold Marx
  • Substituted benzolactam compounds
    Publication number: 20030105124
    Abstract: This invention relates to compounds of the general formula (1): 1
    Type: Application
    Filed: April 27, 2000
    Publication date: June 5, 2003
    Inventor: Susan Beth Sobolov-Jaynes
  • Benzoamide piperidine containing compounds and related compounds
    Publication number: 20030087925
    Abstract: The present invention relates to certain benzoamide piperidine containing compounds and related compounds that exhibit activity as NK-1 receptor antagonists, (e.g., substance P receptor antagonists), to pharmaceutical compositions containing them, and to their use in the treatment and prevention of central nervous system disorders, inflammatory disorders, cardiovascular disorders, ophthalmic disorders, gastrointestinal disorders, disorders caused by helicobacter pylori, disorders of the immune system, urinary incontinence, pain, migraine, emesis, angiogenesis and other disorders.
    Type: Application
    Filed: March 16, 2001
    Publication date: May 8, 2003
    Inventors: Brian Thomas O'Neill, Arthur Adam Nagel, John Michael Humphrey, Susan Beth Sobolov-Jaynes, Thomas Allen Chappie, Lawrence Albert Vincent, Eric Platt Arnold, Jianhua Huang
  • Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
    Patent number: 6492383
    Abstract: The invention relates to compounds of the formulas 1 and 2 and to pharmaceutically acceptable salts and hydrates thereof, wherein X1, R1, R2 and R11 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formulas 1 and 2 and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formulas 1 and 2.
    Type: Grant
    Filed: February 10, 2000
    Date of Patent: December 10, 2002
    Assignee: Pfizer Inc.
    Inventors: Michael John Munchhof, Susan Beth Sobolov-Jaynes, Matthew Arnold Marx
  • Fused bicyclic pyrimidine derivatives
    Patent number: 6413971
    Abstract: The invention relates to compounds of the formula and to pharmaceutically acceptable salts thereof, wherein R1, R2 and Z are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of using said compounds in the treatment of hyperproliferative diseases such as cancer.
    Type: Grant
    Filed: May 19, 1999
    Date of Patent: July 2, 2002
    Assignee: Pfizer Inc
    Inventors: Lee Daniel Arnold, Mikel Paul Moyer, Susan Beth Sobolov-Jaynes
  • Combination treatment for depression and anxiety
    Publication number: 20020049211
    Abstract: The present invention relates to a method of treating depression or anxiety in a mammal, including a human, by administering to the mammal a CNS-penetrant NK-1 receptor antagonist (e.g., a substance P receptor antagonist) in combination with a 5HT1D receptor antagonist. It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier, a CNS-penetrant NK-1 receptor antagonist and a 5HT1D receptor antagonist.
    Type: Application
    Filed: May 29, 2001
    Publication date: April 25, 2002
    Inventors: Susan Beth Sobolov-Jaynes, Christopher Joseph Schmidt
  • FUSED BICYCLIC PYRIMIDINE DERIVATIVES
    Publication number: 20020045630
    Abstract: The invention relates to compounds of the formula 1
    Type: Application
    Filed: May 19, 1999
    Publication date: April 18, 2002
    Inventors: LEE DANIEL ARNOLD, MIKEL PAUL MOYER, SUSAN BETH SOBOLOV-JAYNES